Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
3 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
(Updates dateline, rewrites lede and adds Roche-Rona Therapeutics deal) Oct 13 (Reuters) — Rona Therapeutics said on Tuesday it has signed a licensing deal worth up to $1.16 billion with Swiss drugmaker Roche for an experimental obesity drug candidate. It is the latest in a wave of deals between Chinese biotech compani
Factbox lists recent licensing deals between major drugmakers and Chinese biotechs, including Novo Nordisk's pact with Jiangsu Hengrui for an experimental weight-loss pill. It also cites several deals involving Merck, Pfizer, Eli Lilly, Bristol Myers Squibb, GSK and Roche.
Merck agreed to pay Chinese biotech SciBrunch Therapeutics $400 million upfront for global rights to an experimental cancer drug.